InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,222.68
(
0.00%
)
US TECH 100
17,750.00
(
0.38%
)
Dow Jones
39,512.84
(
0.00%
)
Brent Oil
83.04
(
0.80%
)
Bitcoin
62,815.65
(
2.23%
)
Post# of 17420
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

biotech_researcher

Send PM Follow Ignore
Followers 82
Posts 12433
Boards Moderated 0
Alias Born 07/25/2008

biotech_researcher

Re: None

Friday, 07/21/2017 3:47:21 PM

Friday, July 21, 2017 3:47:21 PM

Post# of 17420
The only disappointing thing is that the combination drug that is used in AUPH's ph 3 trial is CellCept. CellCept is a chemotherapy agent.

I have a disrespect for chemo therapy agents in general for what they do..

I was hoping for a targeted therapy for this disease..
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent AUPH News
More AUPH News
InvestorsHub NewsWire

Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM

VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM

Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM

Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM

Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM

Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM

Start posting your company's news
Only $200 per official company press release!